R. Kalinova et al.
Reactive and Functional Polymers 157 (2020) 104763
preventing their opsonization and uptake by the RES, thus prolonging
the circulation time [16]. Other suitable hydrophilic biocompatible
polymers include poly(N-vinyl-2-pyrrolidone), poly(2-hydroxyethyl
methacrylate), poly(2-oxazoline)s, poly(acrylic acid) [17–20].
recrystallized from toluene/ethyl acetate mixture (95:5 v/v). Triethyl-
amine (TEA, 99%) was distilled from potassium hydroxide. Methox-
ypolyoxyethylene (MPEO-5 K, Mn = 5000 g molꢀ 1) was freeze-dried
from toluene. 2,2-Bis(hydroxymethyl)propionic acid (98%), propargyl
bromide (80 wt% in toluene), ethyl chloroformate (97%), 4-dimethyla-
minopyridine (DMAP, >99%), CuI (≥99.5%), N,N-diisopropylethyl-
amine (DIPEA, ≥99%), potassium hydroxide, Na2SO4 (≥99.0%), diethyl
ether (for analysis), dichloromethane (DCM, ≥99.5%), hexane (>99%),
acetone (≥99.5%) and acetonitrile, (99.8%) were used as received.
Cinnamyl azide was obtained reacting cinnamyl chloride and NaN3 in
water/acetone mixture [35]. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) was purchased from Sigma. Ea.hy926
human endothelial hybrid cell line was purchased from ECACC (Salis-
bury, Wiltshire, England). The cells were maintained in DMEM medium,
supplemented with fetal calf serum, 2 mmol Lꢀ 1 glutamine and HAT at
37 ◦C, humidified air and 5% CO2. The cells were subcultured when they
reach 70–80% confluence by trypsinization.
Caffeic acid phenethyl ester (CAPE) is a natural, bioactive hydro-
phobic, polyphenolic compound found in various plants and is a key
constituent of propolis [21,22]. It can also be prepared by various
chemical and enzyme-catalyzed methods [22,23]. CAPE has attracted an
increasing interest due to its antioxidant, anti-inflammatory, antimi-
crobial, antiviral and anticancer activities, as well as for its neuro-
protective, cardioprotective, and hepatoprotective properties [24–26].
A number of in vitro studies demonstrated CAPE’s ability to suppress the
proliferation of several human cancer cell lines, whereas in vivo evalu-
ations revealed that CAPE prevents cancer initiation, tumor growth, and
cancer metastasis of the colon, liver, and breast cancers in animal
models [27]. The cytotoxic effects of CAPE are usually selective against
cancer cells [28]. However, in order to achieve the therapeutic effect,
CAPE should be able to reach the target tissues at a specific concentra-
tion, which has to be maintained for a prolonged period of time. A
contemporary approach to overcome the drug’s poor water solubility is
to load it into the hydrophobic core of amphiphilic copolymer micelles,
thus achieving increased solubility and stability. Various nanocarriers
formed from biodegradable and biocompatible polymers were used to
encapsulate CAPE. Thus, CAPE loaded PLGA micelles showed sustain-
able and prolonged drug release and enhanced antibacterial and anti-
parasitic activity [29,30]. CAPE-loaded PCL-based amphiphilic diblock
and triblock copolymers with PEO hydrophilic blocks showed higher
anticancer and antioxidant activity, enhanced stability and compati-
bility between CAPE and the micellar core [31–33]. Polymeric micelles
from the amphiphilic diblock copolymers consisting of hydrophilic
polyglycidol and hydrophobic poly(allylglycidyl ether) were also used
as CAPE carriers [34]. Overall, CAPE-incorporated polymer nano-
carriers were found to be more efficient as compared to the drug itself
due to the improved properties (e.g. solubility) and effects.
2.2. Synthetic procedures
2.2.1. Synthesis of 5-methyl-5-propargyloxycarbonyl-1,3-dioxane-2-one
(PC) [36]
2,2-Bis(hydroxymethyl)propionic acid (6 g, 44.7 mmol) and potas-
sium hydroxide (2.74 g, 48.8 mmol) were dissolved in 33 mL of DMF.
The mixture was stirred for 1.5 h at 100 ◦C. Propargyl bromide (8.2 mL,
80 wt% solution in toluene) was then added dropwise and the mixture
was stirred at 70 ◦C for another 40 h. After the mixture was cooled to
room temperature, the solids were filtered off and the filtrate was
concentrated under vacuum. The residue was dissolved in 10 mL of
distilled water and extracted with DCM (3 × 30 mL). The organic phase
was dried over Na2SO4 and DCM was removed in vacuum yielding
propargyl-2,2-bis(hydroxymethylpropionate) as a clear viscous liquid
(6.3 g, 82%).
Propargyl-2,2-bis(hydroxymethylpropionate) (6.3 g, 37 mmol) and
ethyl chloroformate (8.03 g, 74 mmol) were dissolved in 100 mL of THF
at 0 ◦C and the mixture was stirred for 30 min followed by a dropwise
addition of TEA (8.99 g, 88 mmol) over a period of 30 min. After the
mixture was stirred at room temperature for 24 h, the NEt3.HCl salts
were filtered off and the filtrate was concentrated in vacuum to obtain a
viscous liquid. The product was recrystallized from diethyl ether to give
light brown crystals. Yield: 40%. 1H NMR (600 MHz, CDCl3, δ, ppm):
1.37 (s, 3H, -CH3), 2.54 (t, 1H, -CH2-C ≡ CH), 4.23–4.24 (d, 2H, -CH2-C
(CH3)-CH2-), 4.72–4.74 (d, 2H, -CH2-C(CH3)-CH2-), 4.79 (d, 2H, -CH2-C
≡ CH).
The properties of the reported so far polymer nanocarriers of CAPE
were adjusted just through variation of the hydrophilic-hydrophobic
balance as a result of series of polymerizations. Herein, we present a
novel synthetic strategy towards well-defined multifunctional amphi-
philic PLA-PEO-based copolymers with finely tunable number of cin-
namyl side groups distributed along the hydrophobic block. Thus, with
no need of synthesizing a series of amphiphilic copolymers with
different hydrophilic-hydrophobic ratio the delicate balance between
enhanced stability of drug loaded polymer micelles and the successful
cargo release into the target site could be achieved just by attaching the
desired number of cinnamyl side groups onto the same reactive func-
tional block copolymer precursor. A controlled ring-opening copoly-
merization of cyclic monomers was initiated by PEO-macroinitiator
followed by the attachment of the desired amount of side groups to the
copolymers’ hydrophobic segment via highly efficient “click” reactions.
The copolymers self-associated in aqueous media to form micelles
intended for CAPE-loading. Modification of PLA-core with cinnamyl
groups was designed aiming to enhance micelles’ and CAPE stability
2.2.2. Synthesis of MPEO-b-(PLA-co-PPCA) (ВА)
Initially, MPEO-5 K (1 g, 0.2 mmol), D,L-lactide (0.8 g, 5.6 mmol), PC
(0.2 g, 1 mmol) and DMAP (48.9 mg, 0.4 mmol) were dried under high
vacuum for 2 h followed by flushing the flask with an argon. The
polymerization was carried out in bulk at 125 ◦C for 24 h. The crude
product was extracted with 2-propanol, filtered and dried under vacuum
at 30 ◦C. The product was purified by precipitation from DCM/diethyl
ether. Yield: 1.5 g (75%). 1H NMR (600 MHz, CDCl3, δ, ppm): 1.29 (t,
3H, -CH3PPC), 1.56 (t, 3H, -CH3PLA), 2.52 (s, 1H, -CH2-C ≡ CH), 3.38 (s,
3H, CH3-O), 3.65 (s, 4H, -O-CH2-CH2-O-), 4.30–4.35 (d, 2H, -O-CH2-
CH2-O(C=O)- + 4H, (-O-CH2-C(CH3)-CH2-O), 4.73 (s, 2H, -CH2-C ≡ CH),
5.17 (m, 1H, CH-(CH3)-O-).
through π-π stacking interactions between the aromatic groups. The
safety of the developed polymer micelles was evaluated by measuring
their hemolytic potential in freshly isolated erythrocytes and by scratch
test in vitro. The cytotoxic effects of the empty and CAPE-loaded micelles
on endothelial cell line were investigated aiming to explore their po-
tential as drug delivery system.
2.2.3. “Click” reaction of cinnamyl azide with MPEO-b-(PLA-co-PPCA)
block copolymer (BC)
2. Materials and methods
Typically, MPEO-b-(PLA-co-PPCA) (0.4 g, 0.035 mmol) and CuI
(0.027 g, 0.14 mmol) were dried under high vacuum for 30 min followed
by flushing the flask with argon. Then, a solution of cinnamyl azide
(0.086 g, 0.54 mmol) in 2 mL THF was added to the reaction vessel with
a glass syringe and the reaction mixture was degassed by bubbling argon
for 30 min. Finally, DIPEA (0.1 mL, 0.074 g, 0.57 mmol) was added and
2.1. Materials and reagents
All chemicals were purchased from Sigma-Aldrich. Tetrahydrofuran
(THF, >99%) and N,N-dimehylformamide (DMF, ≥99.5%) were
distilled from calcium hydride prior to use. D,L-lactide (LA) was
2